Background Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, there has been increasing urgency to identify pathophysiological characteristics leading to severe clinical course in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Human leukocyte antigen alleles (HLA) have been suggested...
-
October 11, 2022 (v1)PublicationUploaded on: March 24, 2023
-
December 7, 2022 (v1)Publication
ABSTRACT The objective was to evaluate the accuracy of a single determination of IgM antibodies for hepatitis E virus (HEV) diagnosis in patients with acute hepatitis. A prospec tive study included patients with suspicion of HEV infection, defined as individuals with acute hepatitis showing negative results for serological and molecular markers...
Uploaded on: March 24, 2023 -
November 17, 2022 (v1)Publication
CD46 is the main receptor for complement protein C3 and plays an important role in adaptive immune responses. CD46 genetic variants are associated with susceptibility to several infectious and autoimmune diseases. Additionally, CD46 function can be subverted by HIV-1 to evade attack by complement, a strategy shared by viruses of other families....
Uploaded on: March 24, 2023 -
July 2, 2021 (v1)Publication
Background: The aim of the study was to analyze the different impact of standard and low-dose Peg-IFN-a2a/RBV therapies on HCV viral decline in HIV/HCV genotype 3 co-infected patients during the first weeks of treatment. Methods: Plasma HCV viral decline was analyzed between baseline and weeks 1, 2 and 4 in two groups of treatment-naı¨ve HCV...
Uploaded on: December 4, 2022 -
September 29, 2020 (v1)Publication
Background: Acute hepatitis C virus (HCV) infection (AHCVI) outbreaks have been described recently within defined areas worldwide among HIV-infected homosexual men. This study aims to describe the cumulative frequency and incidence of firstly acquired AHCVI in an HIV-infected population in Southern Spain. Methods: This is a retrospective study...
Uploaded on: December 4, 2022 -
June 1, 2023 (v1)Publication
Background & Aim Hepatitis E virus (HEV) was considered the only member of the Hepeviridae family with zoonotic potential. Nevertheless, this consideration has been reassessed owing to several reported cases of acute and chronic hepatitis linked to the Orthohepevirus C genus. Because the circulation of Orthohepevirus C in rodents has been...
Uploaded on: June 2, 2023 -
November 14, 2022 (v1)Publication
Primary aim was to assess prevalence and severity of potential and real drug–drug interactions (DDIs) among therapies for COVID‑19 and concomitant medications in hospitalized patients with confirmed SARS‑CoV‑2 infection. The secondary aim was to analyze factors associated with rDDIs. An observational single center cohort study conducted at a...
Uploaded on: March 24, 2023 -
November 8, 2022 (v1)Publication
Characterization of the genetic landscape of Alzheimer's disease (AD) and related dementias (ADD) provides a unique opportunity for a better understanding of the associated pathophysiological processes. We performed a two-stage genome-wide association study totaling 111,326 clinically diagnosed/'proxy' AD cases and 677,663 controls. We found...
Uploaded on: December 4, 2022 -
September 19, 2022 (v1)Publication
Emerging studies have suggested several chromosomal regions as potential host genetic factors involved in the susceptibility to SARS-CoV-2 infection and disease outcome. We nested a COVID-19 genome-wide association study using the GR@ACE/DEGESCO study, searching for susceptibility factors associated with COVID-19 disease. To this end, we...
Uploaded on: December 4, 2022 -
December 9, 2022 (v1)Publication
Liver stiffness (LS) at sustained virological response (SVR) after direct-acting antivirals (DAA)-based therapy is a predictor of liver events in hepatitis C virus (HCV)-infected patients. The study aim was to identify genetic factors associated with LS changes from the moment of starting anti-HCV therapy to SVR. This prospective study included...
Uploaded on: February 22, 2023 -
November 8, 2022 (v1)Publication
The initiation of antiretroviral treatment based on a 2-drug regimen (2DR) with dolutegravir plus lamivudine has demonstrated non-inferior efficacy than dolutegravir-based three-drug regimens (3DR). We aimed to assess whether the treatment initiation with this 2DR has a different impact on the CD4/CD8 ratio recovery than INSTI-based...
Uploaded on: March 24, 2023 -
October 3, 2022 (v1)Publication
Long runs of homozygosity (ROH) are contiguous stretches of homozygous genotypes, which are a footprint of inbreeding and recessive inheritance. The presence of recessive loci is suggested for Alzheimer's disease (AD); however, their search has been poorly assessed to date. To investigate homozygosity in AD, here we performed a finescale ROH...
Uploaded on: March 24, 2023